Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity

Yun Liang(Shandong University of Traditional Chinese Medicine), Xiaoying Zhao(Handan College), Xi Qiu(Second Affiliated Hospital of Zhejiang University), Rongzhen Xu(Qilu University of Technology)
Journal of Zhejiang University SCIENCE B
June 30, 2011
10.1631/jzus.b1000230
Cited by 25

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2013|247
Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis
|BMC Cancer|2014|146
Systemic Lupus Erythematous and Malignancy Risk: A Meta-Analysis
|PLoS ONE|2015|115